Monocytes arriving at the site of infection differentiate into functional effector macrophages to replenish the resident sentinel cells. Bordetella pertussis, the pertussis agent, secretes an adenylate cyclase toxin-hemolysin (CyaA) that binds myeloid phagocytes through complement receptor 3 (CD11b/CD18) and swiftly delivers its adenylyl cyclase enzyme domain into phagocytes. This ablates the bactericidal capacities of phagocytes through massive and unregulated conversion of cytosolic ATP into the key signaling molecule cAMP. We show that exposure of primary human monocytes to as low a concentration as 22.5 pM CyaA, or a low (2:1) multiplicity of infection by CyaA-producing B. pertussis bacteria, blocks macrophage colony-stimulating factor (M-CSF)-driven differentiation of monocytes. CyaA-induced cAMP signaling mediated through the activity of protein kinase A (PKA) efficiently blocked expression of macrophage markers, and the monocytes exposed to 22.5 pM CyaA failed to acquire the characteristic intracellular complexity of mature macrophage cells. Neither M-CSF-induced endoplasmic reticulum (ER) expansion nor accumulation of Golgi bodies, mitochondria, or lysosomes was observed in toxin-exposed monocytes, which remained small and poorly phagocytic and lacked pseudopodia. Exposure to 22.5 pM CyaA toxin provoked loss of macrophage marker expression on in vitro differentiated macrophages, as well as on primary human alveolar macrophages, which appeared to dedifferentiate into monocyte-like cells with upregulated CD14 levels. This is the first report that terminally differentiated tissue-resident macrophage cells can be dedifferentiated in vitro The results suggest that blocking of monocyte-to-macrophage transition and/or dedifferentiation of the sentinel cells of innate immunity through cAMP-elevating toxin action may represent a novel immune evasion strategy of bacterial pathogens.IMPORTANCE Macrophages are key sentinel cells of the immune system, and, as such, they are targeted by the toxins produced by the pertussis agent Bordetella pertussis The adenylate cyclase toxin (CyaA) mediates immune evasion of B. pertussis by suspending the bactericidal activities of myeloid phagocytes. We reveal a novel mechanism of potential subversion of host immunity, where CyaA at very low (22 pM) concentrations could inhibit maturation of human monocyte precursors into the more phagocytic macrophage cells. Furthermore, exposure to low CyaA amounts has been shown to trigger dedifferentiation of mature primary human alveolar macrophages back into monocyte-like cells. This unprecedented capacity is likely to promote survival of the pathogen in the airways, both by preventing maturation of monocytes attracted to the site of infection into phagocytic macrophages and by dedifferentiation of the already airway-resident sentinel cells.

Department of Respiratory Medicine Thomayer Hospital Prague Czech Republic

Laboratory of Molecular Biology of Bacterial Pathogens Institute of Microbiology of the CAS Prague Czech Republic

Laboratory of Molecular Structure Characterization Institute of Microbiology of the CAS Prague Czech Republic

Zobrazit více v PubMed

Vojtova J, Kamanova J, Sebo P. 2006. Bordetella adenylate cyclase toxin: a swift saboteur of host defense. Curr Opin Microbiol 9:69–75. doi:10.1016/j.mib.2005.12.011. PubMed DOI

Linhartova I, Bumba L, Masin J, Basler M, Osicka R, Kamanova J, Prochazkova K, Adkins I, Hejnova-Holubova J, Sadilkova L, Morova J, Sebo P. 2010. RTX proteins: a highly diverse family secreted by a common mechanism. FEMS Microbiol Rev 34:1076–1112. doi:10.1111/j.1574-6976.2010.00231.x. PubMed DOI PMC

Guermonprez P, Khelef N, Blouin E, Rieu P, Ricciardi-Castagnoli P, Guiso N, Ladant D, Leclerc C. 2001. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med 193:1035–1044. doi:10.1084/jem.193.9.1035. PubMed DOI PMC

Bumba L, Masin J, Fiser R, Sebo P. 2010. Bordetella adenylate cyclase toxin mobilizes its beta2 integrin receptor into lipid rafts to accomplish translocation across target cell membrane in two steps. PLoS Pathog 6:e1000901. doi:10.1371/journal.ppat.1000901. PubMed DOI PMC

Morova J, Osicka R, Masin J, Sebo P. 2008. RTX cytotoxins recognize beta2 integrin receptors through N-linked oligosaccharides. Proc Natl Acad Sci U S A 105:5355–5360. doi:10.1073/pnas.0711400105. PubMed DOI PMC

Guo Q, Shen Y, Lee YS, Gibbs CS, Mrksich M, Tang WJ. 2005. Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin. EMBO J 24:3190–3201. doi:10.1038/sj.emboj.7600800. PubMed DOI PMC

Wolff J, Cook GH, Goldhammer AR, Berkowitz SA. 1980. Calmodulin activates prokaryotic adenylate cyclase. Proc Natl Acad Sci U S A 77:3841–3844. doi:10.1073/pnas.77.7.3841. PubMed DOI PMC

Kamanova J, Kofronova O, Masin J, Genth H, Vojtova J, Linhartova I, Benada O, Just I, Sebo P. 2008. Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling. J Immunol 181:5587–5597. doi:10.4049/jimmunol.181.8.5587. PubMed DOI

Confer DL, Eaton JW. 1982. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science 217:948–950. doi:10.1126/science.6287574. PubMed DOI

Cerny O, Anderson KE, Stephens LR, Hawkins PT, Sebo P. 2017. cAMP signaling of adenylate cyclase toxin blocks the oxidative burst of neutrophils through Epac-mediated inhibition of phospholipase C activity. J Immunol 198:1285–1296. doi:10.4049/jimmunol.1601309. PubMed DOI

Cerny O, Kamanova J, Masin J, Bibova I, Skopova K, Sebo P. 2015. Bordetella pertussis adenylate cyclase toxin blocks induction of bactericidal nitric oxide in macrophages through cAMP-dependent activation of the SHP-1 phosphatase. J Immunol 194:4901–4913. doi:10.4049/jimmunol.1402941. PubMed DOI

Ahmad JN, Cerny O, Linhartova I, Masin J, Osicka R, Sebo P. 2016. cAMP signalling of Bordetella adenylate cyclase toxin through the SHP-1 phosphatase activates the BimEL-Bax pro-apoptotic cascade in phagocytes. Cell Microbiol 18:384–398. doi:10.1111/cmi.12519. PubMed DOI

Khelef N, Zychlinsky A, Guiso N. 1993. Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect Immun 61:4064–4071. PubMed PMC

Ecker J, Liebisch G, Englmaier M, Grandl M, Robenek H, Schmitz G. 2010. Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc Natl Acad Sci U S A 107:7817–7822. doi:10.1073/pnas.0912059107. PubMed DOI PMC

Skopova K, Tomalova B, Kanchev I, Rossmann P, Svedova M, Adkins I, Bibova I, Tomala J, Masin J, Guiso N, Osicka R, Sedlacek R, Kovar M, Sebo P. 2017. Cyclic AMP-elevating capacity of adenylate cyclase toxin-hemolysin is sufficient for lung infection but not for full virulence of Bordetella pertussis. Infect Immun 85:e00937-16. doi:10.1128/IAI.00937-16. PubMed DOI PMC

Jakubzick CV, Randolph GJ, Henson PM. 2017. Monocyte differentiation and antigen-presenting functions. Nat Rev Immunol 17:349–362. doi:10.1038/nri.2017.28. PubMed DOI

Osicka R, Osickova A, Basar T, Guermonprez P, Rojas M, Leclerc C, Sebo P. 2000. Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites. Infect Immun 68:247–256. doi:10.1128/IAI.68.1.247-256.2000. PubMed DOI PMC

Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD, Andreesen R. 1996. Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 60:540–545. doi:10.1002/jlb.60.4.540. PubMed DOI

Gantner F, Kupferschmidt R, Schudt C, Wendel A, Hatzelmann A. 1997. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors. Br J Pharmacol 121:221–231. doi:10.1038/sj.bjp.0701124. PubMed DOI PMC

Passlick B, Flieger D, Ziegler-Heitbrock HW. 1989. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74:2527–2534. PubMed

Burnette WN, Cieplak W, Mar VL, Kaljot KT, Sato H, Keith JM. 1988. Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope. Science 242:72–74. doi:10.1126/science.2459776. PubMed DOI

Cockle SA. 1989. Identification of an active-site residue in subunit S1 of pertussis toxin by photocrosslinking to NAD. FEBS Lett 249:329–332. doi:10.1016/0014-5793(89)80652-0. PubMed DOI

Locht C, Coutte L, Mielcarek N. 2011. The ins and outs of pertussis toxin. FEBS J 278:4668–4682. doi:10.1111/j.1742-4658.2011.08237.x. PubMed DOI

Christensen AE, Selheim F, de Rooij J, Dremier S, Schwede F, Dao KK, Martinez A, Maenhaut C, Bos JL, Genieser H-G, Døskeland SO. 2003. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J Biol Chem 278:35394–35402. doi:10.1074/jbc.M302179200. PubMed DOI

Gjertsen BT, Mellgren G, Otten A, Maronde E, Genieser HG, Jastorff B, Vintermyr OK, McKnight GS, Doskeland SO. 1995. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action. J Biol Chem 270:20599–20607. doi:10.1074/jbc.270.35.20599. PubMed DOI

Liu S, Morris SM Jr, Nie S, Shapiro RA, Billiar TR. 2000. cAMP induces CD14 expression in murine macrophages via increased transcription. J Leukoc Biol 67:894–901. doi:10.1002/jlb.67.6.894. PubMed DOI

Purves GI, Kamishima T, Davies LM, Quayle JM, Dart C. 2009. Exchange protein activated by cAMP (Epac) mediates cAMP-dependent but protein kinase A-insensitive modulation of vascular ATP-sensitive potassium channels. J Physiol 587:3639–3650. doi:10.1113/jphysiol.2009.173534. PubMed DOI PMC

de Rooij J, Rehmann H, van Triest M, Cool RH, Wittinghofer A, Bos JL. 2000. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 275:20829–20836. doi:10.1074/jbc.M001113200. PubMed DOI

Shi C, Pamer EG. 2011. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11:762–774. doi:10.1038/nri3070. PubMed DOI PMC

Rougerie P, Miskolci V, Cox D. 2013. Generation of membrane structures during phagocytosis and chemotaxis of macrophages: role and regulation of the actin cytoskeleton. Immunol Rev 256:222–239. doi:10.1111/imr.12118. PubMed DOI PMC

Sarantis H, Grinstein S. 2012. Subversion of phagocytosis for pathogen survival. Cell Host Microbe 12:419–431. doi:10.1016/j.chom.2012.09.001. PubMed DOI

Sansonetti PJ, Di Santo JP. 2007. Debugging how bacteria manipulate the immune response. Immunity 26:149–161. doi:10.1016/j.immuni.2007.02.004. PubMed DOI

McDonough KA, Rodriguez A. 2012. The myriad roles of cyclic AMP in microbial pathogens: from signal to sword. Nat Rev Microbiol 10:27–38. doi:10.1038/nrmicro2688. PubMed DOI PMC

Morse SI, Morse JH. 1976. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis. J Exp Med 143:1483–1502. doi:10.1084/jem.143.6.1483. PubMed DOI PMC

Andreasen C, Carbonetti NH. 2008. Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect Immun 76:5139–5148. doi:10.1128/IAI.00895-08. PubMed DOI PMC

Osicka R, Osickova A, Hasan S, Bumba L, Cerny J, Sebo P. 2015. Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3. Elife 4:e10766. doi:10.7554/eLife.10766. PubMed DOI PMC

Melvin JA, Scheller EV, Miller JF, Cotter PA. 2014. Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol 12:274–288. doi:10.1038/nrmicro3235. PubMed DOI PMC

Mantovani A. 1994. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 71:5–16. PubMed

Pollard JW. 2004. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71–78. doi:10.1038/nrc1256. PubMed DOI

Hume DA, MacDonald KP. 2012. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 119:1810–1820. doi:10.1182/blood-2011-09-379214. PubMed DOI

Cebon J, Layton JE, Maher D, Morstyn G. 1994. Endogenous haemopoietic growth factors in neutropenia and infection. Br J Haematol 86:265–274. doi:10.1111/j.1365-2141.1994.tb04725.x. PubMed DOI

Bettina A, Zhang Z, Michels K, Cagnina RE, Vincent IS, Burdick MD, Kadl A, Mehrad B. 2016. M-CSF mediates host defense during bacterial pneumonia by promoting the survival of lung and liver mononuclear phagocytes. J Immunol 196:5047–5055. doi:10.4049/jimmunol.1600306. PubMed DOI PMC

Nelson S, Daifuku R, Andresen J. 1994. Use of filgrastim (r-metHuGCSF) in infectious diseases, p 253–266. In Morstyn G, Dexter TM (ed), Filgrastim (r-metHuG-CSF) in clinical practice. Dekker, New York, NY.

Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW. 2002. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 7:147–162. doi:10.1023/A:1020399802795. PubMed DOI

Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW. 1995. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin Cancer Res 1:313–325. PubMed

Kacinski BM. 1997. CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol Reprod Dev 46:71–74. doi:10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6. PubMed DOI

Pattabiraman DR, Bierie B, Kober KI, Thiru P, Krall JA, Zill C, Reinhardt F, Tam WL, Weinberg RA. 2016. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability. Science 351:aad3680. doi:10.1126/science.aad3680. PubMed DOI PMC

Franken KL, Hiemstra HS, van Meijgaarden KE, Subronto Y, den Hartigh J, Ottenhoff TH, Drijfhout JW. 2000. Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr Purif 18:95–99. doi:10.1006/prep.1999.1162. PubMed DOI

Stibitz S. 1994. Use of conditionally counterselectable suicide vectors for allelic exchange. Methods Enzymol 235:458–465. doi:10.1016/0076-6879(94)35161-9. PubMed DOI

Buasri W, Impoolsup A, Boonchird C, Luengchaichawange A, Prompiboon P, Petre J, Panbangred W. 2012. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated pertussis toxin and pertactin by unmarked allelic exchange. BMC Microbiol 12:61. doi:10.1186/1471-2180-12-61. PubMed DOI PMC

Lee SJ, Gray MC, Guo L, Sebo P, Hewlett EL. 1999. Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxin. Infect Immun 67:2090–2095. PubMed PMC

Keidel K, Amman F, Bibova I, Drzmisek J, Benes V, Hot D, Vecerek B. 2018. Signal transduction-dependent small regulatory RNA is involved in glutamate metabolism of the human pathogen Bordetella pertussis. RNA 24:1530–1541. doi:10.1261/rna.067306.118. PubMed DOI PMC

Karimova G, Pidoux J, Ullmann A, Ladant D. 1998. A bacterial two-hybrid system based on a reconstituted signal transduction pathway. Proc Natl Acad Sci U S A 95:5752–5756. doi:10.1073/pnas.95.10.5752. PubMed DOI PMC

Reynolds ES. 1963. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208–212. doi:10.1083/jcb.17.1.208. PubMed DOI PMC

cAMP signaling of Bordetella adenylate cyclase toxin blocks M-CSF triggered upregulation of iron acquisition receptors on differentiating CD14+ monocytes

Pertussis toxin suppresses dendritic cell-mediated delivery of B. pertussis into lung-draining lymph nodes

The Fim and FhaB adhesins play a crucial role in nasal cavity infection and Bordetella pertussis transmission in a novel mouse catarrhal infection model

Kingella kingae RtxA Cytotoxin in the Context of Other RTX Toxins

Selective Enhancement of the Cell-Permeabilizing Activity of Adenylate Cyclase Toxin Does Not Increase Virulence of Bordetella pertussis

Bordetella Adenylate Cyclase Toxin Elicits Airway Mucin Secretion through Activation of the cAMP Response Element Binding Protein

Almost half of the RTX domain is dispensable for complement receptor 3 binding and cell-invasive activity of the Bordetella adenylate cyclase toxin

Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice

Adenylate Cyclase Toxin Tinkering With Monocyte-Macrophage Differentiation